Skip to main content
Premium Trial:

Request an Annual Quote

Peter Wrighton-Smith

Inviata has appointed Peter Wrighton-Smith to its board of directors. He comes to Inviata's board with strategic product development and international commercialisation experience in addition to a broad understanding of the clinical service testing market. Wrighton-Smith is the current CEO and founder of Oxford Immunotec where he has overseen the company raise five rounds of venture funding prior to an IPO on NASDAQ in 2013.